Jun Ye, Jiang Huang, Chongwei Zhou, Zhijin Yuan, Haiping Guan, Zhiyou Long, Haini Chen, Wenfeng Li
{"title":"Transcriptomic characteristics of plasma from Chinese ethnic minority patients with major depressive disorder.","authors":"Jun Ye, Jiang Huang, Chongwei Zhou, Zhijin Yuan, Haiping Guan, Zhiyou Long, Haini Chen, Wenfeng Li","doi":"10.1038/s41398-026-04342-6","DOIUrl":null,"url":null,"abstract":"<p><p>Ethnic and regional disparities have been observed in the diagnosis and treatment of psychiatric disorders. Our previous research revealed metabolic heterogeneity in plasma samples from ethnic minority patients with schizophrenia in Qiandongnan, China. In this study, individuals of Han, Miao, and Dong ethnicities with major depressive disorder (MDD) from Qiandongnan, China, were enrolled. Peripheral blood samples were collected from both the MDD groups of these ethnicities and their corresponding healthy control (HC) groups for transcriptomic analysis. Ethnicity-specific genes and signaling pathways were identified. Specifically, the genes B3GNTL1, DNASE2, and OAS3 may distinguish individuals of Han ethnicity. The gene ELANE may distinguish individuals of Miao ethnicity. The gene SETSIP may distinguish individuals of Dong ethnicity. Transcriptomic heterogeneity in peripheral blood was observed among Han, Miao, and Dong ethnic groups with MDD from Qiandongnan, China. Furthermore trans-ethnically consistent genes and pathways may uncover the core mechanisms of depression. These findings may provide novel insights into diagnosis and treatment strategies for depression.</p>","PeriodicalId":23278,"journal":{"name":"Translational Psychiatry","volume":"16 1","pages":""},"PeriodicalIF":7.5000,"publicationDate":"2026-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13550567/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41398-026-04342-6","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
Ethnic and regional disparities have been observed in the diagnosis and treatment of psychiatric disorders. Our previous research revealed metabolic heterogeneity in plasma samples from ethnic minority patients with schizophrenia in Qiandongnan, China. In this study, individuals of Han, Miao, and Dong ethnicities with major depressive disorder (MDD) from Qiandongnan, China, were enrolled. Peripheral blood samples were collected from both the MDD groups of these ethnicities and their corresponding healthy control (HC) groups for transcriptomic analysis. Ethnicity-specific genes and signaling pathways were identified. Specifically, the genes B3GNTL1, DNASE2, and OAS3 may distinguish individuals of Han ethnicity. The gene ELANE may distinguish individuals of Miao ethnicity. The gene SETSIP may distinguish individuals of Dong ethnicity. Transcriptomic heterogeneity in peripheral blood was observed among Han, Miao, and Dong ethnic groups with MDD from Qiandongnan, China. Furthermore trans-ethnically consistent genes and pathways may uncover the core mechanisms of depression. These findings may provide novel insights into diagnosis and treatment strategies for depression.
期刊介绍:
Psychiatry has suffered tremendously by the limited translational pipeline. Nobel laureate Julius Axelrod''s discovery in 1961 of monoamine reuptake by pre-synaptic neurons still forms the basis of contemporary antidepressant treatment. There is a grievous gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients. Translational Psychiatry bridges this gap by fostering and highlighting the pathway from discovery to clinical applications, healthcare and global health. We view translation broadly as the full spectrum of work that marks the pathway from discovery to global health, inclusive. The steps of translation that are within the scope of Translational Psychiatry include (i) fundamental discovery, (ii) bench to bedside, (iii) bedside to clinical applications (clinical trials), (iv) translation to policy and health care guidelines, (v) assessment of health policy and usage, and (vi) global health. All areas of medical research, including — but not restricted to — molecular biology, genetics, pharmacology, imaging and epidemiology are welcome as they contribute to enhance the field of translational psychiatry.